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MinireviewT Cell Development: Bottoms-Up
genes encoding these molecules. Most of what we knowStephen M. Hedrick1
about thymocyte selection at a cellular and molecularDepartment of Biology and
level comes from such studies, and if the goal is to proveThe Cancer Center
that TCR and coreceptor signaling mediate the fate deci-University of California, San Diego
sion and selection events, then we’re most of the wayLa Jolla, California 92093
there. On the other hand, if the goal is to understand
the logic of the cell underlying the commitment to one
or another lineage, then we have a long way to go.An important but laborious approach to understanding
Proximal signaling radiating from the TCR and CD4/8the concepts underlying T cell lineage commitment is
coreceptors geometrically expands as the pathways ex-to characterize the cis-acting control elements gov-
tend and branch. Another way of thinking about this iserning the expression of CD4 and CD8. Previous stud-
that signaling “pathways” don’t exist as such. There areies on the CD4 gene have shown that lineage commit-
only signaling webs, or in the extreme, a single signalingment information is directed by the intronic silencer;
web that can be perturbed by membrane proximalhowever, a similarly simple mechanism for controlling
events. This web of interactions can provoke manyCD8 gene expression has not been uncovered. In this
downstream events, and a subset of these may in turnissue of Immunity, two groups have investigated the
set up a network of transcription factors that mutuallyrole of putative enhancers in the CD8 locus. The dele-
regulate each other’s expression. It is very difficult, iftion of three different elements in the intergeneic re-
not impossible, to determine the logic underlying differ-gion between CD8 and CD8 provides evidence for
entiation by reverse genetics and signaling biochemis-control at the level of chromatin accessibility.
try. So while taking the “top-down” can be enticingly
fruitful and seductively rapid, it has its limitations.There are a large number of fate decisions that guide
So a student of T cell development might ask, “whatorganismal development. Modern chordates have from
else is there?” The answer is a “bottoms-up” method.100–300 mature cell types that must pass through nu-
Before describing this, there is an alternate modus oper-merous precursor states on the path from an undifferen-
andi, also seductive, but also fraught with pitfalls. Thattiated zygote to a specialized, terminally differentiated
is to take advantage of the forward genetic studies car-cell. Each of these cytodifferentiation events is based
ried out in simple metazoans. Tens of thousands ofon a contingency, some of which have been defined;
organisms can be screened for mutations based onhowever, there are few examples of fate decisions that
observed phenotypes in a particular developmentaldepend upon the selective expression of a diverse set of
pathway. Through this type of analysis, with associatedreceptors. Axonal guidance related to olfactory receptor
epistasis studies, there has emerged the logic of devel-expression comes to mind, and although there are likely
opmental contingencies guiding many types of differen-to be further examples, the development of lymphocytes
tiation events. For most vertebrate biologists, the notionis unusual in this regard. Thymocytes differentiate into
of a genetic screen, though not impossible, is but aphenotypically distinct types of T cells based on the
dream. The tempting shortcut is to assume (or ratherspecificity of the T cell receptor for antigen (TCR). From
hope) that the concepts underlying all metazoan devel-myriad studies, we know that thymocytes expressing a
opment have, to some extent, been conserved, and the
TCR specific for MHC class II differentiate into CD4 T
orthologs of signaling cascades in worms, flies, and
helper cells and thymocytes expressing a TCR specific
mice have similar functions. Having been guilty of a
for MHC class I differentiate into CD8 T killer cells. We zealous subscription to this approach, my sense is that
know that the incipient T cells recognize the MHC mole- it is fine as a start, but the thymus is no hermaphroditic
cules expressed on thymic epithelium as the introduc- vulva. The implication here is that there is indeed a
tion to a life-long need for validation provided by T cell- tremendous degree of conservation in mechanisms gov-
APC interactions. This selection event thus imbues the erning analogous developmental processes. The prob-
T cell population with two apparently fundamental char- lem for immunologists is that the adaptive immune sys-
acteristics. It selects for a population that can interro- tem is limited to vertebrates. With time, genetic screens
gate APCs for the presence of a foreign peptide, and it for revealing mutations in T cell development may be
associates T cell function with the recognition of endog- possible in zebrafish or even mice.
enous or exogenous antigen. Understanding these pro- To understand the logic of development, we are look-
cesses of selection and fate determination has thus ing for the path from an initiating signal to a program
been an area of active research over many years. of changes in gene expression. The path starts simply,
One approach to understanding thymocyte selection but becomes rapidly distributed through many different
and CD4 versus CD8 lineage commitment has been to signaling molecules and transcription factors. In study-
take a “top-down” approach. Such studies include the ing a discrete cytodifferentiation event, the question be-
biochemical identification of molecules that mediate comes: is it easier to try every fork in the path until you
TCR-mediated signaling events, and more recently, the find the direct route from the membrane to a particular
study of immune development in the face of disregulated gene, or is it easier to start with the gene and work
backward toward the inciting event? If the analogy is a
tree and the goal is find the direct route from the trunk1Correspondence: shedrick@ucsd.edu
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to a particular leaf, is it not far easier to start with the More recent progress has been made in describing
the the control of CD8 expression, and the combinationleaf and follow the convergence back to the trunk? This
is the bottoms-up approach. A slow but sure road to of studies describing CD4 and CD8 gene regulation may
be key in understanding the logic of lineage commit-understanding the logic of differentiation is to first de-
scribe the control of a developmentally regulated set of ment. The CD8 locus consists of two genes, CD8 and
CD8, tandemly arranged in the same transcriptionalgenes. The studies can then be extended to determine
which of the control elements are differentially regulated orientation and interspersed with DNase-hypersensitive
sites (Figure 1). An 80 kb region of murine DNA or a 96during development, how those control elements inter-
act with transcription factors, and ultimately how tran- kb region of human DNA appears to be sufficient to
confer CD8 expression that is physiological for bothscription factors are regulated by extrinsic signals. The
control elements can be diverse in type and function transcriptional levels and cell-type specificity (Hostert
et al., 1997a; Kieffer et al., 1997); however, one caveatand include sequences mediating chromatin accessibil-
ity and matrix attachment in addition to classically de- to this is that there exists evidence for posttranslational
regulation of CD8 (Takahama and Singer, 1992; Gaofined enhancers, silencers, and promoters. A priori,
there is no way to know which combination of se- et al., 1996; Cibotti et al., 2000). A possibility is that
CD8 gene expression may not reflect the lineage com-quences is responsible for lineage-specific expression.
To understand CD4 versus CD8 lineage commitment, mitment decision, but rather regulation is at the level of
message stability.several laboratories have committed to a full description
of the transcriptional control of the two defining genes, The DNase-hypersensitive sites of the CD8 locus, can-
didates for cis-acting control elements, were found toCD4 and CD8 (Ellmeier et al., 1999). The first insights
came from studying the transcriptional regulation of be present in four clusters (Cluster I–IV), each consisting
of three hypersensitive sites, with the exception of theCD4. The control elements include a strong upstream,
lymphocyte-specific enhancer (Sawada and Littman, six sites present in Cluster IV (Hostert et al., 1997b). The
transcriptional regulation of the CD8 locus was attacked1991), a proximal promoter (Siu et al., 1992), and perhaps
more interestingly, an intronic silencer (Sawada et al., by using these putative control elements to express
reporters in transgenic mice (Ellmeier et al., 1999). E8I/1994; Siu et al., 1994). A previously characterized distal
enhancer is actually upstream of the tandemly arranged Cluster III was found in several studies to recapitulate
CD8 expression in mature CD8 T cells and intraepithelialCD4 homolog, LAG-3, and presumably serves as a
LAG-3 enhancer (Wurster et al., 1994; Bruniquel et al., lymphocytes (IELs) and was commonly assumed to be
an essential lineage-directed CD8 control element. Sur-1997). LAG-3 and CD4 have entirely distinct patterns of
gene regulation where LAG-3 is expressed on activated prisingly, deletion of this element resulted in almost no
change in CD8 expression in thymus-dependent T cellsCD4 and CD8 T cells (CD8  CD4), and this despite
that fact that the CD4 enhancer, located between the but caused the loss of CD8 expression in IELs (Ellmeier
et al., 1998; Hostert et al., 1998). E8II/CIV, found betweentwo genes, is actually closer to LAG-3. The silencer is
apparently the key to understanding CD4 gene regula- CD8 and CD8, directed complete CD8 T cell-specific
expression in that it was shown to drive reporter expres-tion, since it inhibits transcription in early thymocytes,
CD8 T cells, B cells, and macrophages. sion in CD8 T cells, mature CD8 thymocytes, and DP
thymocytes (Zhang et al., 1998). This was perhaps theThe transgene studies describing CD4 silencer ele-
ments (Duncan et al., 1996; Donda et al., 1996) have best candidate for the lineage-specific CD8 control el-
ement.now been verified and extended by the construction of
mice with a targeted deletion (Zou et al., 2001; Leung In this issue of Immunity, two groups have further
explored lineage commitment at the level of gene tran-et al., 2001). In these mice, CD4 expression was found
in the CD8 lineage even when the silencer was deleted scription (Ellmeier et al., 2002; Garefalaki et al., 2002).
In each study, putative regulatory elements from thelate in thymic maturation after CD4 gene expression was
already turned off; however, deletion of the silencer in CD8 locus were deleted by homologous recombination,
and CRE recombinase was used to delete the selectionmature T cells did not restore CD4 expression in CD8
T cells. This implies that there may be an epigenetic marker flanked by loxP sites. Using this procedure, all
that remains at the site of recombination is a single 34alteration of the CD4 locus, subsequent to lineage com-
mitment, that disallows chromatin accessibility. The si- bp loxP site. In one study by Littman and his colleagues
(Ellmeier et al., 2002), the E8II/CIV-5 enhancer was de-lencer is thus important for commitment but not mainte-
nance of cell-type-specific expression, and thus it would leted and tested along with a double mutation of E8II
and E8I. Gene regulation, especially in the CD8 locus,appear to reflect the signals that govern T cell differenti-
ation. Defining the binding sites would seem to be a never fails to surprise. The E8II deletion had no measur-
able effect, but when combined with the E8I deletionformidable task given that each putative site may require
the creation of another targeted deletion, but amazingly there was found to be variegated expression of CD8
within the DP subset, reduced numbers of mature CD8a series of more than a dozen mutations has been pro-
duced and analyzed to do just that (D. Littman, personal T cells, but virtually no effect on CD8 expression in T
cells found in peripheral lymphoid organs. In the othercommunication). These studies should lay the ground-
work for the identification of important transcription fac- study by Kioussis and his colleagues (Garefalaki et al.,
2002), the Cluster II-1,2 sites (named E8V in Figure 1)tors that guide the developmental control of CD4 gene
expression. Note that these studies are not for the faint were deleted. Remarkably, this deletion also produced
variegated expression in DP thymocytes with a measur-of heart; 8 years have elapsed between the description
of the CD4 silencer and the extensive analysis of the able diminution of CD8 expression in mature T cells.
These groups came to the same conclusions, namelysilencer gene elements in mutant mice.
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Figure 1. cis-Acting Elements Characterized in the CD8 Locus
that these gene elements act to alter chromatin structure believe that E8V would have sufficient activity to confer
the CD8 expression in thymus-dependent T cells. Whator compartmentalization, and in their absence there is
a diminished probability that the locus will be accessible are the alternatives? One possibility is that there are
other as yet undefined control elements within the de-to the factors that initiate and maintain transcription in
CD8 T cells. In addition, the decrease in CD8 levels of marcated CD8 locus that have yet to be identified. They
would seem to be undetectable by DNase-hypersensi-expression imply that E8V/Cluster II has weak enhancer
activity. Garefalaki et al. (2002) propose that the locus tivity analysis. A second possibility is that the multiple
cis-acting elements, including those within the intronichas numerous Ikaros binding sites, and Ikaros has been
shown to affect nuclear compartmentalization. In addi- regions of CD8, combine to drive CD8 lineage-spe-
cific expression. This is certainly a possibility. Fromtion, in the human CD8 gene complex, identification of
multiple HS sites that bind SATB1, a protein that tethers transgene experiments, E8IV confers expression of CD8
in lymphocytes, and E8III confers expression in DP thy-chromatin to the nuclear matrix, further suggests the
potential importance of subnulcear localization in CD8 mocytes. The differential expression of CD8 and CD8
can be explained by the activity of E8I that directs exclu-transcription (Kieffer et al., 2002). Thus, these DNase-
hypersensitive sites may activate the promoters present sive expression of CD8 in IELs. In this case, E8I would
exhibit polarity toward CD8, yet E8IV and E8III wouldin the CD8 locus by segregating them into regions of
active transcription. act on both genes. This would require an insulating ele-
ment that acts only in one direction. A third possibility,How is lineage-specific cell surface expression of CD8
achieved? The control elements analyzed in these two albeit unlikely, is that there is no lineage-specific control
of CD8. Its transcription is driven by the promoter, andpapers were chosen for good reason: they were the
most likely candidates for a CD8 enhancer. Transgenes the putative enhancers function by changing chromatin
accessibility and nuclear compartmentalization. Eitherthat include both of the most proximal DNase-hypersen-
sitive sites to CD8, CII/E8V, and CI have no transcrip- the promoter would have to exhibit CD8 T cell specificity
or the regulation would have to be posttranscriptional.tional activity. The DNase-hypersensitive sites upstream
of CD8 but not within the CD8 gene are Clusters CIV- At this point, despite the extensive and elegant studies
on CD8 gene expression from a number of groups, there5,6/E8II and CIII/E8I, and these were previously found to
confer strong CD8 T cell-specific expression (Figure 1). is no clearly defined cis-acting control element or ele-
ments that respond to the lineage commitment decision.Yet, these two enhancers were deleted in combination
to no avail. A remaining possibility is that the deletion As for bottoms-up, the CD8 locus is not yet ready to
reveal the logic underlying the CD4 versus CD8 lineageof E8II, E8I, and E8V would eliminate CD8-specific gene
expression; however, without E8II and E8I it is hard to contingency. The studies presented in this issue of Im-
Immunity
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munity suggest that CD8 expression is not simply gov-
erned by the known gene elements and that we may
need to look beyond classically defined transcriptional
regulation for the answers.
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